| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |